Alzheimer’s disease

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited[...]

By sjmartinez • September 6, 2024

Keller MS, Guevara N, Guerrero JA, Mays AM, McCleskey SG, Reyes CE, Sarkisian CA. Experiences managing behavioral symptoms among Latino caregivers of Latino older adults[...]

By sjmartinez • September 2, 2024

Nianogo RA, Hays RD, Gong Y, Yu Y, Ritz B, Duru OK. The Role of Inflammation and Psycho-Behavioral Factors as Mediators Between Acculturation and Time[...]

By sjmartinez • September 1, 2024

Ross FC, Mayer DE, Horn J, Cryan JF, Del Rio D, Randolph E, Gill CIR, Gupta A, Ross RP, Stanton C, Mayer EA. Potential of[...]

By sjmartinez • January 30, 2024

Hanson LC, Wessell K, Meeks N, Bennett AV, Toles M, Niznik J, Zimmerman S, Carpenter J, Ritchie CS, Ernecoff NC, Saliba D. Selecting outcomes for[...]

By sjmartinez • November 2, 2023

Pardridge WM. Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. Front Drug Deliv. 2023;3:1227816. doi: 10.3389/fddev.2023.1227816. Epub 2023 Jul 10. PMID: 37583474;[...]

By sjmartinez • August 16, 2023

Piras IS, Brokaw D, Kong Y, Weisenberger DJ, Krate J, Delvaux E, Mahurkar S, Blattler A, Siegmund KD, Sue L, Serrano GE, Beach TG, Laird[...]

By sjmartinez • June 26, 2023

Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476. PMID: 35890374; PMCID: PMC9322584.

By rosaguerrero • July 28, 2022